ClinicalTrials.gg

Supplement

Bifidobacterium longum subsp. infantis clinical trials

Also written Bifidobacterium infantis.

studies test it
7
open now
0
in phase 3
0
first study started
2009

How studies write it

Studies that test it under each name

Studies by the year they started

7 studies that test it; most in 2009 (2)

Studies that test Bifidobacterium longum subsp. infantis, by start year
YearStudies
20092
20102
20132
20181

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
1
Phase 4
1
No phase
3

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 0 · Other 7

University of California, Davis (2) · Ochsner Health System (1) · American Academy of Family Physicians (1) · Stanford University (1) · Women's College Hospital (1) · University of Reading (1)

Often tested with

Tested in the same studies.

Pancrelipase (1) · Nitazoxanide (1) · Human milk oligosaccharides (1) · Bifidobacterium animalis (1) · Limosilactobacillus reuteri DSM-17938 (1)

Studies

Open first, then newest update. How each study uses Bifidobacterium longum subsp. infantis is read from its arms, and is right about nine times in ten.

Testing it · 7

Codes

What other systems call Bifidobacterium longum subsp. infantis · ClinicalTrials.gg INT016452

  • RxNorm 100213One source FDA
  • Wikidata Q21365185Bifidobacterium longum subsp. infantisOne source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.